Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics
Open Access
- 12 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1447567
Abstract
In recent years, significant advancements have been made in utilizing nanoparticles (NPs) to modulate immune responses within the central nervous system (CNS), offering new opportunities for nanotherapeutic interventions in neurological disorders. NPs can serve as carriers for immunomodulatory agents or platforms for delivering nucleic acid-based therapeutics to regulate gene expression and modulate immune responses. Several studies have demonstrated the efficacy of NP-mediated immune modulation in preclinical models of neurological diseases, including multiple sclerosis, stroke, Alzheimer’s disease, and Parkinson’s disease. While challenges remain, advancements in NPs engineering and design have led to the development of NPs using diverse strategies to overcome these challenges. The nano-bio interface with the immune system is key in the conceptualization of NPs to efficiently act as nanotherapeutics in the CNS. The biomolecular corona plays a pivotal role in dictating NPs behavior and immune recognition within the CNS, giving researchers the opportunity to optimize NPs design and surface modifications to minimize immunogenicity and enhance biocompatibility. Here, we review how NPs interact with the CNS immune system, focusing on immunosurveillance of NPs, NP-induced immune reprogramming and the impact of the biomolecular corona on NPs behavior in CNS immune responses. The integration of NPs into CNS nanotherapeutics offers promising opportunities for addressing the complex challenges of acute and chronic neurological conditions and pathologies, also in the context of preventive and rehabilitative medicine. By harnessing the nano-bio immune interface and understanding the significance of the biomolecular corona, researchers can develop targeted, safe, and effective nanotherapeutic interventions for a wide range of CNS disorders to improve treatment and rehabilitation. These advancements have the potential to revolutionize the treatment landscape of neurological diseases, offering promising solutions for improved patient care and quality of life in the future.Keywords
This publication has 239 references indexed in Scilit:
- The Blood–Brain BarrierCold Spring Harbor Perspectives in Biology, 2015
- Biological properties of extracellular vesicles and their physiological functionsJournal of Extracellular Vesicles, 2015
- Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson’s and other brain diseasesFrontiers in Neuroanatomy, 2014
- Pattern recognition receptors and central nervous system repairExperimental Neurology, 2014
- Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in miceNeuroscience, 2012
- The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological SystemsAnnual Review of Biomedical Engineering, 2012
- Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent MannerNeuron, 2012
- Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNature Nanotechnology, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006